tiprankstipranks
Trending News
More News >

Allogene Therapeutics price target lowered to $8 from $9 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Allogene Therapeutics (ALLO) to $8 from $9 and keeps a Buy rating on the shares following the Q4 report.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1